A clinical view on BET inhibition in targeting residual risk in cardiovascular disease and diabetes.
25 August 2018 (16:10 - 16:25)
Organised by:
About the speaker
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Professor E. Stroes (Amsterdam, NL)
Doctor J. Plutzky (Boston, US)
Access the full session
The Event
ESC Congress 2018
25 August 2018
16:10 CET
